APR May/June 2022 - 88
» ADVERTISER'S INDEX
»
Company
Adare Pharma Solutions
AdvantaPure
Ascendia Pharma
Ashland
Associates of Cape Cod
BASF
Capitsol
Catalent
Celanese
Discovery on Target
Eurofins PSS Insourcing Solutions
Gattefosse
IMA Life
JRS Pharma
MIDI Labs
MilliporeSigma
Nelson Labs
Next-Generation DX Summit
Particle Measuring Systems Webinar
Sartorius
SOTAX
SUEZ Water Technologies
TriLink Biotechnologies
LIVE & On-Demand WEBINAR
The Data Quality Journey -
Focus on Environmental Monitoring Systems
REGISTER at https://bit.ly/3zd6Laa
This webinar will guide you into the journey of
data, with a specific focus on Environmental
Monitoring Systems for pharmaceutical
cleanroom.
We will dig into the design, implementation and
validation of an EMS as essential steps to ensure
generation of meaningful data, then we will
describe best practices to enable data to become
" information " , and support improvement or
correction decision.
What You'll Learn:
* How to ensure your Environmental Monitoring
System is properly designed and validated, with
specific reference to the selection of sampling
point and risk based approach
* How to properly configure alert and action
limits, and ensure a continuous adjustment/
improvements of them, according ISO
standards
* How to make multidimensional analysis of data,
to identify contamination root cause
and generate CAPA
Who should attend:
All Pharmaceutical cleanroom users, especially
those working in the following departments:
* Quality Assurance
* Quality Control
* Information Technology
* Engineering
* Production
LIVE June 22nd, 2022 * 8 a.m PT, 11 a.m. ET
View On Demand after June 22
88 |
| May/June 2022
PRESENTER
Daniele Pandolfi
Product Line Manager Systems,
Particle Measuring Systems
MODERATOR
Mike Auerbach
Editor in Chief,
American Pharmaceutical Review
Page #
19
53
21
13
5
23
11
CV4
25
59
43
1
17, CV2
15
47
29
49
45
88
31
CV3
2
37
Web Address
www.adarepharmasolutions.com
www.advantapure.com
www.ascendiapharma.com
www.ashland.com
www.acciusa.com
www.pharma.basf.com
www.captisol.com
www.catalent.com/onexpress
www.vitaldose.com
www.DiscoveryOnTarget.com
www.Eurofins.com/PSS
www.gattefosse.com
www.ima.it
www.jrspharma.com
www.midilabs.com
www.SigmaAldrich.com/BiologicsQC
www.nelsonlabs.com
www.NextGenerationDX.com
https://bit.ly/3zd6Laa
www.sartorius.com/cld-services
www.sotax.com
www.suezwatertechnologies.com
www.trilinkbiotech.com
The advertiser's index is for information purposes only. While every effort has been made to ensure it is accurate and complete, any errors or omissions are not the responsibility of the publisher.
http://www.adarepharmasolutions.com
http://www.advantapure.com
http://www.ascendiapharma.com
http://www.ashland.com
http://www.acciusa.com
http://www.pharma.basf.com
http://www.captisol.com
http://www.catalent.com/onexpress
http://www.vitaldose.com
http://www.DiscoveryOnTarget.com
http://www.Eurofins.com/PSS
http://www.gattefosse.com
http://www.ima.it
http://www.jrspharma.com
http://www.midilabs.com
http://www.SigmaAldrich.com/BiologicsQC
http://www.nelsonlabs.com
http://www.NextGenerationDX.com
https://www.bit.ly/3zd6Laa
http://www.sartorius.com/cld-services
http://www.sotax.com
http://www.suezwatertechnologies.com
http://www.trilinkbiotech.com
https://www.bit.ly/3zd6Laa
APR May/June 2022
Table of Contents for the Digital Edition of APR May/June 2022
Message from the Editor
Editorial Advisory Board
CN Perspectives
Social Media Connections
BIOPHARMACEUTICALS - Long-Acting Injectable Suspensions
ROUNDTABLE - Controlled Release
QC CORNER - Affinity Approaches to Selective, Sensitive MS Assays
DRUG DELIVERY - Introduction to mRNA-LNPs, Their Manufacture and Future Perspectives
BIOPHARMACEUTICALS - A Next-Generation Workforce for Next- Generation Therapies Preparing for Cell and Gene Therapies
MICROBIOLOGY - Optimizing a Viral Testing Strategy
BIOPHARMACEUTICAL - Assuring Quality of Oligonucleotide APIs and DPs
FACILITY TOUR - Growing to Serve: Eurofins’ Portage, Michigan, Facility Expands to Offer New Capabilities and Services
VENDOR VIEWPOINT - Combining the Best of Both Worlds with Semi-Targeted Metabolomics
VENDOR VIEWPOINT - Method Changes for Bacterial Endotoxins Testing (BET): Steps to Follow for a Straightforward Process
An Interview with Tony Saavedra Sievers DataShare Elite Stoftware
Editor's Top Tech
MANUFACTURING - A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
Equipment Focus
MICROBIOLOGY - Cleaning and Disinfection: An Important Pillar of Contamination Control
P.I.N. Points
Advertiser's Index
APR May/June 2022 - Cover1
APR May/June 2022 - Cover2
APR May/June 2022 - 1
APR May/June 2022 - 2
APR May/June 2022 - 3
APR May/June 2022 - 4
APR May/June 2022 - 5
APR May/June 2022 - Message from the Editor
APR May/June 2022 - Editorial Advisory Board
APR May/June 2022 - CN Perspectives
APR May/June 2022 - Social Media Connections
APR May/June 2022 - BIOPHARMACEUTICALS - Long-Acting Injectable Suspensions
APR May/June 2022 - 11
APR May/June 2022 - 12
APR May/June 2022 - 13
APR May/June 2022 - 14
APR May/June 2022 - 15
APR May/June 2022 - 16
APR May/June 2022 - 17
APR May/June 2022 - ROUNDTABLE - Controlled Release
APR May/June 2022 - 19
APR May/June 2022 - 20
APR May/June 2022 - 21
APR May/June 2022 - 22
APR May/June 2022 - 23
APR May/June 2022 - 24
APR May/June 2022 - 25
APR May/June 2022 - 26
APR May/June 2022 - 27
APR May/June 2022 - QC CORNER - Affinity Approaches to Selective, Sensitive MS Assays
APR May/June 2022 - 29
APR May/June 2022 - 30
APR May/June 2022 - 31
APR May/June 2022 - 32
APR May/June 2022 - 33
APR May/June 2022 - 34
APR May/June 2022 - 35
APR May/June 2022 - DRUG DELIVERY - Introduction to mRNA-LNPs, Their Manufacture and Future Perspectives
APR May/June 2022 - 37
APR May/June 2022 - 38
APR May/June 2022 - 39
APR May/June 2022 - 40
APR May/June 2022 - 41
APR May/June 2022 - BIOPHARMACEUTICALS - A Next-Generation Workforce for Next- Generation Therapies Preparing for Cell and Gene Therapies
APR May/June 2022 - 43
APR May/June 2022 - 44
APR May/June 2022 - 45
APR May/June 2022 - MICROBIOLOGY - Optimizing a Viral Testing Strategy
APR May/June 2022 - 47
APR May/June 2022 - 48
APR May/June 2022 - 49
APR May/June 2022 - 50
APR May/June 2022 - 51
APR May/June 2022 - BIOPHARMACEUTICAL - Assuring Quality of Oligonucleotide APIs and DPs
APR May/June 2022 - 53
APR May/June 2022 - 54
APR May/June 2022 - 55
APR May/June 2022 - 56
APR May/June 2022 - 57
APR May/June 2022 - 58
APR May/June 2022 - 59
APR May/June 2022 - FACILITY TOUR - Growing to Serve: Eurofins’ Portage, Michigan, Facility Expands to Offer New Capabilities and Services
APR May/June 2022 - 61
APR May/June 2022 - 62
APR May/June 2022 - VENDOR VIEWPOINT - Combining the Best of Both Worlds with Semi-Targeted Metabolomics
APR May/June 2022 - 64
APR May/June 2022 - 65
APR May/June 2022 - VENDOR VIEWPOINT - Method Changes for Bacterial Endotoxins Testing (BET): Steps to Follow for a Straightforward Process
APR May/June 2022 - 67
APR May/June 2022 - An Interview with Tony Saavedra Sievers DataShare Elite Stoftware
APR May/June 2022 - 69
APR May/June 2022 - Editor's Top Tech
APR May/June 2022 - 71
APR May/June 2022 - MANUFACTURING - A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
APR May/June 2022 - 73
APR May/June 2022 - 74
APR May/June 2022 - 75
APR May/June 2022 - 76
APR May/June 2022 - 77
APR May/June 2022 - 78
APR May/June 2022 - Equipment Focus
APR May/June 2022 - MICROBIOLOGY - Cleaning and Disinfection: An Important Pillar of Contamination Control
APR May/June 2022 - 81
APR May/June 2022 - 82
APR May/June 2022 - 83
APR May/June 2022 - 84
APR May/June 2022 - 85
APR May/June 2022 - P.I.N. Points
APR May/June 2022 - 87
APR May/June 2022 - Advertiser's Index
APR May/June 2022 - Cover3
APR May/June 2022 - Cover4
https://www.nxtbookmedia.com